Erleada is the first and only ARI option avaialable as aa once-daily, single-ta...
Adcendo plans to use the additional funding to advance its uPARAP-focused ADCs.
The company announced the signing of a multimillion-dollar deal, with IND submis...
The WHO recommends that countries offer universal health coverage of fertility t...
“One cannot really access a hospital website in this country without being expos...
Sandoz’s Hyrimoz received approval for all the indications that are covered by t...
Liver cancer is considered to be the third most common cause of cancer death and...
The phase 1/2 clinical study will test the safety, pharmacokinetics, pharmacodyn...
Once developed, the ADCs will join BioNTech’s existing portfolio of oncology pro...
Innate will receive royalties on possible net sales of any commercial product to...
The NDA submission is supported by data from the Phase III FRESCO and FRESCO-2 t...
SAGE also updated its guidance on bivalent Covid-19 vaccines, now recommending t...
The CHMP’s positive opinion was based on the data obtained from the pivotal Phas...
Eisai will be responsible for providing tazemetostat to the National Cancer Cent...
The U.S. Federal Trade Commission on Monday ordered DNA sequencing giant Illumin...
Bluebird's Skysona gene therapy is expected to save the lives of patients with t...
